Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine 2003 Marzo;47(1) > The Quarterly Journal of Nuclear Medicine 2003 Marzo;47(1):41-5

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

  THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E.


The Quarterly Journal of Nuclear Medicine 2003 Marzo;47(1):41-5

lingua: Inglese

Assessment of therapy response by FDG PET in pediatric patients

Franzius C., Schober O.

Depart­ment of ­Nuclear Med­i­cine, Münster Uni­ver­sity, ­Münster, Ger­many


FULL TEXT  


­Little is ­known ­about the clin­ical ­value of FDG PET for ­assessing treat­ment ­response in pedi­atric ­oncology. ­After system­atic ­review of lit­er­a­ture, the ­very few pub­li­ca­tions con­cerning ­response con­trol in pedi­atric ­oncology ­using FDG PET are sum­mar­ized. ­There ­were ­only 4 ­studies con­cerning FDG PET in the assess­ment of ­therapy ­response in pedi­atric ­patients. ­None of the pub­li­ca­tions ful­filled the require­ments for ­high ­quality ­studies ­because of the ­small ­number of ­patients ­studied. The clin­ical ­value of FDG PET in the assess­ment of ­therapy ­response in pedi­atric ­oncology is ­likely in ­osseous sar­comas and pos­sibly in ­high-­grade ­brain ­tumors. In ­other pedi­atric ­tumor ­entities ­such as lym­phomas, ­soft-­tissue sar­comas, ­germ ­cell ­tumors, or neu­ro­blas­tomas, the clin­ical use­ful­ness of FDG PET can ­either be ­assumed anal­o­gous to ­adults, or can be ­assumed ­from ­staging ­studies, or is ­still ­unknown. ­There is a ­need for ­large, system­atic ­studies eval­u­ating FDG PET in ­therapy mon­i­toring, but ­also in ­grading, ­staging, and in the diag­nosis of recur­rences in pedi­atric malig­nan­cies.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail